Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4890056 | 0.77 | TSHR (0.47) | TSHRLMNA | |
| SCHEMBL5157479 | 0.76 | — | — | |
| SCHEMBL7161312 | 0.74 | TSHR (0.31) | TSHRLMNA | |
| SCHEMBL5150501 | 0.74 | LMNA (0.39) | LMNA | |
| SCHEMBL19384644 | 0.73 | — | — | |
| SCHEMBL3105781 | 0.72 | — | — | |
| SCHEMBL7090813 | 0.72 | — | — | |
| SCHEMBL428149 | 0.71 | — | — | |
| SCHEMBL13062787 | 0.71 | — | — | |
| SCHEMBL385785 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1103300-B1 | ULTRAVIOLET IRRADIATION APPARATUS FOR PHOTOCHEMICAL REACTION AND METHOD FOR PREPARING VITAMIN D DERIVATIVE USING THE SAME | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2007-01-03 | — | — | EP | disclosed |
| US-6902654-B2 | Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2005-06-07 | — | — | US | disclosed |
| US-20040108198-A1 | Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2004-06-10 | — | — | US | disclosed |
| EP-1103300-A1 | ULTRAVIOLET IRRADIATION APPARATUS FOR PHOTOCHEMICAL REACTION AND METHOD FOR PREPARING VITAMIN D DERIVATIVE USING THE SAME | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2001-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040108198-A1 | Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same | VDR, GC, CYP24A1 | TSHR 535/4885LMNA 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.